Uckan, K. Et Al. 2021. Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.27, no.2 , 103-108.

Uckan, K., Çeleğen, İ., & Uçkan, T., (2021). Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.27, no.2, 103-108.

Uckan, Kazım, İzzet Çeleğen, And Taner Uçkan. "Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women," VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.27, no.2, 103-108, 2021

Uckan, Kazım Et Al. "Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.27, no.2, pp.103-108, 2021

Uckan, K. Çeleğen, İ. And Uçkan, T. (2021) . "Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.27, no.2, pp.103-108.

@article{article, author={Kazım Uçkan Et Al. }, title={Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women}, journal={VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL}, year=2021, pages={103-108} }